Kopetz Kopetz S S Yoshino Yoshino T T Van Cutsem Van Cutsem E E Eng Eng C C Kim Kim TW TW Wasan Wasan HS HS Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial Nat Med Nat Med 2025 2025 31 31 901 901 8 8 10.1038/s41591-024-03443-3 10.1038/s41591-024-03443-3 39863775 39863775. Here, BRAF is linked to colorectal cancer.